epirubicin has been researched along with Alopecia in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (36.00) | 18.7374 |
| 1990's | 15 (30.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 6 (12.00) | 24.3611 |
| 2020's | 2 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heibloem, RE; Ilozumba, OUC; Komen, MMC; van den Hurk, CJG | 1 |
| Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R | 1 |
| Carlesimo, M; Caro, G; D'Arino, A; Fortuna, MC; Pigliacelli, F; Rossi, A | 1 |
| Komen, MMC; Nieboer, P; Nortier, JWR; Smorenburg, CH; van den Hurk, CJG; van der Hoeven, JJM; van der Ploeg, T | 1 |
| Komen, MMC; Nortier, JWR; Smorenburg, CH; van den Hurk, CJG; van der Hoeven, JJM; van der Ploeg, T | 1 |
| Becerra, CR; Frenkel, EP; Tavana, D; Tran, HT; Verma, UN; Williams, NS | 1 |
| Ding, G; Fu, Q; Ren, H; Su, FX; Wang, N; Wang, YJ; Wu, Q; Yang, JQ; Ye, ZB; Zhang, J; Zhou, LZ | 1 |
| Botti, C; Carpino, A; Colucci, G; Di Lauro, L; Filippelli, G; Giannarelli, D; Giotta, F; Latorre, A; Lopez, M; Perri, P; Pizzuti, L; Sergi, D; Vici, P; Vizza, E | 1 |
| Bessis, D; Dereure, O; Frouin, E; Guillot, B; Jacot, W; Kluger, N; Poujol, S; Rigau, V; Romieu, G | 1 |
| Fan, Y; Li, Q; Ma, F; Wang, JY; Wang, WM; Xu, BH; Yuan, P; Zhang, P | 1 |
| Archibald, H; Hutcheon, A; Macduff, C; Mackenzie, T; Melville, L | 1 |
| Cui, HJ; Li, Y; Tan, HY; Wu, XQ | 1 |
| Alexopoulos, A; Papacharalambous, A; Rigatos, G; Scartsilas, C; Stavrakakis, J; Stavrinidis, E | 1 |
| Hamada, K; Kubota, K; Mori, S; Nakagawa, A; Suzuki, N; Tagaya, N | 1 |
| Hata, Y; Taguchi, K; Takahashi, H; Takahashi, M; Tamura, M; Todo, S; Watanabe, K | 1 |
| Bu, Q; Cai, QQ; Gao, Y; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, XB; Pan, ZH; Wang, BF; Xia, ZJ; Xu, RH | 1 |
| Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Bramwell, V; Bruntsch, U; Cavalli, F; Decoster, G; Dombernowsky, P; Høst, H; Renard, G; Rozencweig, M; ten Bokkel Huinink, W; Van Glabbeke, M | 1 |
| Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, K; Ogawa, M; Okada, Y; Tada, A; Usui, N | 1 |
| Hayashi, K; Kitamura, M; Kosaki, G; Takahashi, I; Tominaga, T | 1 |
| Kemeny, N; Michaelson, R; Young, C | 1 |
| Bonadonna, G; Bonfante, V; Villani, F | 1 |
| Fukuda, K; Kikkawa, N; Kobayashi, K; Mishima, H; Shin, E; Takatsuka, Y; Tono, T; Yagyuu, T | 1 |
| Aapro, M; Amadori, D; Bliss, JM; Chilvers, CE; Coombes, G; Coombes, RC; Espié, M; Ferreira, EP; Gambrosier, P; Marty, M; McArdle, C; Morvan, F; Pérez-López, FR; Richards, M; Vassilopoulos, P; Villar-Grimalt, A; Wils, J; Woods, EM | 1 |
| Diergarten, K; duBois, A; Hecker, D; Janicke, F; Konecny, G; Kuhnle, H; Lindner, C; Lisboa, BW; Luck, HJ; Meerpohl, HG; Thomssen, C; Untch, M | 1 |
| Diergarten, K; du Bois, A; Hecker, D; Jänicke, F; Konecny, G; Kühnle, H; Lindner, C; Lisboa, BW; Lück, HJ; Meerpohl, HG; Thomssen, C; Untch, M | 1 |
| Arisawa, J; Hosoki, T; Inoue, Y; Masuzawa, M; Monden, M; Monden, T; Nakamura, H; Nakao, N; Ohi, H; Ohsaki, Y; Sakon, M; Seki, K; Shimizu, T; Todo, A; Tomono, N; Yayoi, E | 1 |
| Cognetti, F; Gamucci, T; Nardi, M; Serrone, L; Zeuli, M | 1 |
| Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Mellou, S; Nicolaides, C; Papadopoulos, A; Papageogriou, E; Papasavvas, P; Pavlidis, N; Samantas, E; Tsatalas, C | 1 |
| Delozier, T; Vernhes, JC | 1 |
| Delaere, KP; Leliefeld, H; Peulen, F; Smeets, J; Stapper, EW; Wils, J | 1 |
| Benjachai, W; Cheirsilpa, A; Kosiyatrakul, T; Puriphat, S; Tangkrutt, S | 1 |
| Aikawa, T; Kobayashi, T; Kotsuma, Y; Takatsuka, Y; Yayoi, E | 1 |
| Aikawa, T; Furukawa, J; Kaji, M; Kobayashi, T; Kotsuma, Y; Maeura, Y; Takatsuka, Y; Yayoi, E | 1 |
| Armas, A; Asins Codoner, J; Calero, F; Iglesias, J; Jimeno, J; Mendana, J; Murillo, F; Rementería, A; Rodríguez-Escudero, F; Ugalde, F | 1 |
| Guaraldi, M; Martoni, A; Melotti, B; Pannuti, F | 1 |
| Habeshaw, T; Jones, R; Kaye, SB; Paul, J; Rankin, EM; Reed, NS; Soukop, M; Stallard, S; Stewart, M; Symonds, RP | 1 |
| Carmo-Pereira, J; Costa, FO; Henriques, E; Miles, DW; Richards, MA; Rubens, RD | 1 |
| Coombes, RC; Cunningham, D; Haydock, A; Hickish, T | 1 |
| Asaishi, K; Hayasaka, H; Mikami, T; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, H; Toda, K; Watanabe, Y | 1 |
| Bonadonna, G; Bonfante, V; Brambilla, C; Crippa, F; Ferrari, L; Rossi, A; Villani, F | 1 |
| Abe, O; Enomoto, K; Iino, Y; Ikeda, T; Izuo, M; Kitamura, M; Nomura, Y; Taguchi, T; Tamura, K; Tominaga, T | 1 |
| Hayakawa, M; Hayashi, T; Kano, H; Kimura, K; Morise, K; Nagano, I; Nakai, T; Sakakibara, K; Suga, S; Yokoyama, Y | 1 |
| Durrant, KD; Jones, AC; Robinson, MH | 1 |
| Boyd, MA; Case, DC; Ervin, TJ; Gams, R; Oldham, FB | 1 |
| Bruntsch, U; Cavalli, F; Hansen, HH; Holdener, EE; Høst, H; Pinedo, HM; Renard, J; Rozencweig, M | 1 |
| Casper, ES; Cassidy, C; Currie, V; Geller, NL; Hakes, TB; Jain, KK; Kaufman, RJ; Petroni, GR; Schwartz, W; Young, CW | 1 |
| Di Pietro, N; Ganzina, F; Magni, O | 1 |
| Di Lauro, L; Di Pietro, N; Ganzina, F; Lopez, M; Papaldo, P; Perno, CF | 1 |
1 review(s) available for epirubicin and Alopecia
| Article | Year |
|---|---|
[Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature].
Topics: Alopecia; Doxorubicin; Epirubicin; Heart; Humans; Leukopenia; Mitoxantrone; Nausea; Randomized Controlled Trials as Topic | 1991 |
24 trial(s) available for epirubicin and Alopecia
| Article | Year |
|---|---|
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Hair; Humans; Hypothermia, Induced; Neoplasms; Paclitaxel; Registries; Scalp | 2023 |
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Hypothermia, Induced; Induction Chemotherapy; Middle Aged; Palliative Care; Prospective Studies; Scalp; Taxoids | 2019 |
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Camptothecin; Capecitabine; Deoxycytidine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Topoisomerase II Inhibitors; Treatment Outcome | 2008 |
[Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult | 2008 |
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Soft Tissue Neoplasms; Vinblastine; Vinorelbine; Viscera | 2011 |
[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Premenopause; Radiotherapy, Adjuvant; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vomiting | 2012 |
The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Hypothermia, Induced; Paclitaxel; Taxoids; Treatment Outcome | 2003 |
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Random Allocation; Vomiting | 1984 |
[Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
Topics: Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Middle Aged; Prospective Studies | 1995 |
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collab
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Nausea; Premenopause; Regression Analysis; Survival Analysis; Vomiting | 1996 |
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Feasibility Studies; Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Remission Induction | 1996 |
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel | 1997 |
[Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fever; Hepatic Artery; Humans; Injections, Intra-Arterial; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1998 |
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms; Vomiting | 2001 |
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Phase II study of epirubicin in advanced hormone-resistant prostatic carcinoma.
Topics: Aged; Alopecia; Bone Neoplasms; Drug Resistance; Epirubicin; Humans; Male; Middle Aged; Prostatic Neoplasms; Time Factors | 1992 |
[A prospective randomized study of intra-arterial infusion chemotherapy in the treatment of advanced breast cancer].
Topics: Alopecia; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Middle Aged; Postoperative Care; Prospective Studies; Survival Rate | 1992 |
Epirubicin: clinical toxicity during the phase II program in endometrial and cervical cancer.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Endometrial Neoplasms; Epirubicin; Female; Heart; Humans; Leukopenia; Middle Aged; Spain; Uterine Cervical Neoplasms; Vomiting | 1992 |
Activity of high-dose epirubicin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Alopecia; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Stroke Volume | 1991 |
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Prednisolone; Survival Rate; Taste Disorders; Thrombophlebitis | 1991 |
A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Heart Failure; Hematologic Diseases; Humans; Middle Aged; Nausea; Prospective Studies; Survival Rate | 1991 |
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Drug Evaluation; Epirubicin; Female; Humans; Life Tables; Middle Aged; Nausea; Survival Rate; Vomiting | 1991 |
Phase II study of doxorubicin versus epirubicin in advanced breast cancer.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Middle Aged; Mouth Diseases; Vomiting | 1986 |
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
Topics: Actuarial Analysis; Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Erythrocytes; Female; Heart Diseases; Hematologic Diseases; Humans; Middle Aged; Nausea; Physical Examination; Prospective Studies; Radionuclide Imaging; Random Allocation; Stroke Volume; Technetium | 1985 |
25 other study(ies) available for epirubicin and Alopecia
| Article | Year |
|---|---|
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Topics: Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Epirubicin; Eyebrows; Eyelashes; Female; Fluorouracil; Humans; Japan; Middle Aged; Premenopause; Prevalence; Prospective Studies; Scalp; Self Report; Taxoids; Treatment Outcome | 2021 |
Chemotherapy-induced alopecia: A novel observation.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dermoscopy; Epirubicin; Female; Fluorouracil; Hair Color; Humans; Taxoids | 2019 |
Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cryotherapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Scalp; Skin Temperature | 2016 |
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Ficusin; Fluorouracil; Humans; Middle Aged; Minoxidil; Prospective Studies; Spironolactone; Taxoids; Ultraviolet Therapy; Vitamins | 2012 |
[Taxol based chemotherapy in the treatment of advanced gastric cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Remission Induction; Stomach Neoplasms | 2004 |
Second and third line chemotherapy in advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Vinblastine; Vincristine | 1989 |
[Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neutropenia; Pilot Projects; Taxoids | 2006 |
[Efficacy and toxicity of combination treatment with epirubicin (EPI) plus docetaxel (DOC) in advanced breast cancer].
Topics: Adult; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Taxoids | 2006 |
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Thrombocytopenia; Vincristine | 2007 |
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia | 1984 |
[A phase I trial of 4'-epiadriamycin].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Thrombocytopenia | 1984 |
[Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
Topics: Adult; Aged; Alopecia; Anthraquinones; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Middle Aged; Mitoxantrone; Nausea; Neoplasm Recurrence, Local; Vomiting | 1984 |
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Fatigue; Humans; Leukopenia; Middle Aged; Nausea; Rectal Neoplasms; Stereoisomerism; Vomiting | 1982 |
Toxic and therapeutic activity of 4'-epi-doxorubicin.
Topics: Adolescent; Adult; Aged; Alopecia; Arrhythmias, Cardiac; Bone Marrow Diseases; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Middle Aged; Neoplasms; Stereoisomerism; Stomatitis; Vomiting | 1982 |
Primary chemotherapy for locally advanced uterine cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Nausea; Survival Rate; Uterine Cervical Neoplasms; Vomiting | 1992 |
[Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin].
Topics: Alopecia; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Subclavian Artery; Survival Rate | 1992 |
Experience with intermediate-dose (110-120 mg/m2) epirubicin.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Dose-Response Relationship, Drug; Epirubicin; Female; Hematologic Diseases; Humans; Inflammation; Male; Middle Aged; Mucous Membrane; Nausea; Thrombophlebitis | 1989 |
[Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Lymphatic Metastasis; Remission Induction; Thrombocytopenia | 1989 |
[Phase II study of epirubicin on breast cancer: a cooperative group study].
Topics: Adult; Aged; Alopecia; Anorexia; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Middle Aged | 1986 |
[Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Stomach Neoplasms | 1986 |
Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer.
Topics: Alopecia; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Hypothermia, Induced; Liver Neoplasms | 1987 |
Phase I-II trial of high-dose epirubicin in patients with lymphoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Bone Marrow; Doxorubicin; Drug Evaluation; Epirubicin; Fever; Humans; Lymphoma; Middle Aged; Nausea; Stomatitis; Vomiting | 1987 |
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Vomiting | 1985 |
Clinical toxicity of 4'-epi-doxorubicin (epirubicin).
Topics: Alopecia; Bone Marrow; Breast Neoplasms; Doxorubicin; Epirubicin; Heart; Heart Diseases; Humans; Nausea; Vomiting | 1985 |
Epirubicin in non-Hodgkin's lymphomas.
Topics: Adult; Aged; Alopecia; Doxorubicin; Epirubicin; Gastrointestinal Diseases; Humans; Leukopenia; Lymphoma; Middle Aged | 1985 |